Multiple Myeloma: Diagnosis and Treatment

Area of Science:

• Hematology
• Oncology
• Internal Medicine

Background:

• Multiple myeloma is a significant hematologic malignancy in the US, accounting for 10% of such cases.
• The disease disproportionately affects individuals over 65 and Black populations.
• Clinical presentation can be nonspecific, including bone pain, systemic symptoms, or laboratory abnormalities.

Purpose of the Study:

• To outline the diagnostic workup for suspected multiple myeloma.
• To describe the multidisciplinary management approach for multiple myeloma patients.
• To highlight the role of family physicians in ongoing patient care.

Main Methods:

• Diagnostic workup includes complete blood count, serum chemistries, immunoglobulin studies, and bone marrow evaluation.
• Key diagnostic criteria involve abnormal plasma cells, monoclonal proteins, and bone lesions.
• Treatment initiation involves chemotherapy and assessment for stem cell transplantation.

Main Results:

• Diagnosis requires specific hematologic, biochemical, and radiographic findings.
• Management often includes thromboprophylaxis, bisphosphonate therapy, and infection prophylaxis.
• Family physicians are integral in monitoring for complications and providing supportive care.

Conclusions:

• Prompt and accurate diagnosis is essential for effective multiple myeloma management.
• A comprehensive approach involving oncologists and primary care physicians optimizes patient care.
• Ongoing monitoring for treatment-related complications and supportive care are critical components of managing multiple myeloma.